Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate XBiotech Inc. before investing.

In this article, we go over a few key elements for understanding XBiotech Inc.’s stock price such as:

• XBiotech Inc.’s current stock price and volume
• Why XBiotech Inc.’s stock price changed recently
• Upgrades and downgrades for XBIT from analysts
• XBIT’s stock price momentum as measured by its relative strength

About XBiotech Inc. (XBIT)

Before we jump into XBiotech Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes true human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.

Want to learn more about XBiotech Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about XBiotech Inc..

XBiotech Inc.’s Stock Price as of Market Close

As of December 09, 2025, 4:00 PM, CST, XBiotech Inc.’s stock price was $2.400.

XBiotech Inc. is down 1.64% from its previous closing price of $2.440.

During the last market session, XBiotech Inc.’s stock traded between $2.400 and $2.460. Currently, there are approximately 30.49 million shares outstanding for XBiotech Inc..

XBiotech Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

XBiotech Inc. Stock Price History

XBiotech Inc.’s (XBIT) price is currently up 5.73% so far this month.

During the month of December, XBiotech Inc.’s stock price has reached a high of $2.680 and a low of $2.260.

Over the last year, XBiotech Inc. has hit prices as high as $7.240 and as low as $2.090. Year to date, XBiotech Inc.’s stock is down 39.24%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused XBiotech Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of December 08, 2025, there were analysts who downgraded XBiotech Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate XBiotech Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on XBiotech Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

XBiotech Inc.’s current valuation based on AAII’s Value Grade is a A, which means it is considered to be Deep Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about XBiotech Inc. (XBIT) by visiting AAII Stock Evaluator.

Relative Price Strength of XBiotech Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of December 08, 2025, XBiotech Inc. has a weighted four-quarter relative price strength of -21.50%, which translates to a Momentum Score of 8 and is considered to be Very Weak.

Want to learn more about how XBiotech Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

XBiotech Inc. Stock Price: Bottom Line

As of December 9, 2025, XBiotech Inc.’s stock price is $2.400, which is down 1.64% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like XBiotech Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.